Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 38.63B | 37.58B | 35.44B | 32.77B | 16.81B | 13.59B |
Gross Profit | 5.49B | 4.83B | 5.24B | 4.62B | -3.00M | -2.98B |
EBITDA | 3.96B | 4.30B | 5.33B | 3.85B | 31.00M | -5.49B |
Net Income | 1.77B | 1.38B | 1.67B | 791.00M | -2.19B | -6.77B |
Balance Sheet | ||||||
Total Assets | 48.14B | 48.16B | 46.16B | 44.26B | 43.49B | 40.07B |
Cash, Cash Equivalents and Short-Term Investments | 8.59B | 8.49B | 8.27B | 8.30B | 7.67B | 5.46B |
Total Debt | 14.02B | 14.23B | 13.95B | 15.17B | 16.69B | 15.38B |
Total Liabilities | 37.80B | 36.56B | 36.45B | 35.78B | 39.00B | 38.69B |
Stockholders Equity | 10.29B | 11.54B | 9.66B | 8.40B | 4.45B | 1.35B |
Cash Flow | ||||||
Free Cash Flow | 133.00M | -6.00M | 659.00M | 2.66B | -700.00M | -3.58B |
Operating Cash Flow | 3.88B | 3.89B | 4.71B | 5.17B | 618.00M | -2.33B |
Investing Cash Flow | -2.85B | -2.33B | -2.94B | -3.44B | -3.02B | -2.34B |
Financing Cash Flow | -947.00M | -1.45B | -2.07B | -2.27B | 2.87B | 5.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | €9.67B | 5.44 | 17.73% | 3.63% | 6.03% | 78.04% | |
71 Outperform | ¥268.19B | 15.08 | 8.32% | 2.78% | 6.19% | 11.06% | |
― | €7.03B | 17.77 | 8.49% | ― | ― | ― | |
― | €2.01B | 60.65 | 5.42% | ― | ― | ― | |
― | €3.89B | 17.22 | 12.50% | ― | ― | ― | |
― | €3.89B | 11.70 | 12.50% | ― | ― | ― | |
73 Outperform | €15.86B | 7.28 | 12.80% | 5.34% | -2.98% | -14.55% |